info@synchemia.com | sales@synchemia.com 
9766925136 
Raloxifene
Raloxifene | CAS NO: 84449-90-1 , Raloxifene is a selective estrogen receptor modulator (SERM) used to prevent and treat osteoporosis in postmenopausal women by increasing bone density and reducing fracture risk. It is also prescribed to reduce the risk of invasive breast cancer in high-risk postmenopausal women. It acts as an estrogen agonist in bone and an antagonist in breast tissue.
We are the Synchemia Research Chemical specializes in manufacturing and supplying of Raloxifene impurities that meet specific pharmacopeial standards (EP/BP/USP/IP) as well as process-related impurities. Raloxifene is a selective estrogen receptor modulator (SERM) used to prevent and treat osteoporosis in postmenopausal women by increasing bone density and reducing fracture risk. It is also prescribed to reduce the risk of invasive breast cancer in high-risk postmenopausal women. It acts as an estrogen agonist in bone and an antagonist in breast tissue. Buy Reliable and High-Purity Raloxifene Impurities, Delivered by Synchemia Research Chemicals.
Download catalogue
Pharmaceutical Reference Standards
| CAT No | SRC-R18387 |
| CAS No | 174264-50-7 |
| Mol.F. | C34H35NO10S |
| Mol.Wt. | 649.7g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-R18388 |
| CAS No | 618902-12-8 |
| Mol.F. | C56H52N2O8S2 |
| Mol.Wt. | 945.2g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-R18389 |
| CAS No | 63676-22-2 |
| Mol.F. | C14H10O2S |
| Mol.Wt. | 242.3g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-R18390 |
| CAS No | 84449-65-0 |
| Mol.F. | C16H14O6S3 |
| Mol.Wt. | 398.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-R18391 |
| CAS No | 1932-03-2 |
| Mol.F. | C7H14ClN : HCl |
| Mol.Wt. | 147.6 : 36.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-R18392 |
| CAS No | 2632-13-5 |
| Mol.F. | C9H9BrO2 |
| Mol.Wt. | 229.1g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-R18393 |
| CAS No | NA |
| Mol.F. | C42H44N2O6S |
| Mol.Wt. | 704.9g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-R18394 |
| CAS No | 225648-21-5 |
| Mol.F. | C15H12O2S |
| Mol.Wt. | 256.3g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-R18395 |
| CAS No | 175460-94-3 |
| Mol.F. | C15H12O2S |
| Mol.Wt. | 256.3g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-R18396 |
| CAS No | 1677681-01-4 |
| Mol.F. | C20H26N2O4S |
| Mol.Wt. | 390.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-R18397 |
| CAS No | 1677681-02-5 |
| Mol.F. | C18H22N2O4S |
| Mol.Wt. | 362.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-R18398 |
| CAS No | 1700655-67-9 |
| Mol.F. | C13H14N2O2S : HCl |
| Mol.Wt. | 262.3 : 36.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-R18399 |
| CAS No | 3040-44-6 |
| Mol.F. | C7H15NO |
| Mol.Wt. | 129.2g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-R18400 |
| CAS No | NA |
| Mol.F. | C14H10O2S |
| Mol.Wt. | 242.3g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-R79221 |
| CAS No | NA |
| Mol.F. | C14H10O2S |
| Mol.Wt. | 242.3g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-R79222 |
| CAS No | 1305861-81-7 |
| Mol.F. | C16H16O3S |
| Mol.Wt. | 288.4g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Let’s advance your research together.
Partner with us for specialized chemical materials and synthesis services that enable pharmaceutical innovation.
